writing a clinical research
play

Writing a Clinical Research Manuscript that Has Impact For Early - PowerPoint PPT Presentation

Download at: edanzediting.com/ftm_2015 Writing a Clinical Research Manuscript that Has Impact For Early Career Researchers Faculty of Tropical Medicine 11 May 2015 Dr Jeffrey Robens Dr William Yajima Your goal is not only to be published,


  1. Topic position Effective writing sentence idea idea idea idea Topic link The patient went to the hospital to see a gastroenterologist . The doctor then performed a series of diagnostic tests . The results showed the patient suffered from a bacterial infection . Antibiotics were prescribed to treat the infection before the patient developed an ulcer .

  2. Linking your ideas in Effective writing your manuscript Topic sentence Lung cancer is the leading cause of cancer mortality for men and women. Despite smoking prevention and cessation programs and advances in early detection, the 5-year survival rate for lung cancer is only 16% with current therapies. Although lung cancer incidence rates have recently declined in the Support United States, more lung cancer is now diagnosed when considered together in former- and never-smokers than in current smokers. Thus, even if all of the national anti-smoking campaign goals are met, lung cancer will remain a major public health problem for decades. New ways to treat or prevent lung cancer are therefore needed. Stress sentence One potential therapeutic target for lung cancer is the Wnt signaling pathway. The canonical Wnt signaling pathway in mammals consists of a family of Topic sentence secreted lipid-modified Wnt protein ligands that bind to a family of 7-pass transmembrane Frizzled (Fzd) receptors, as reviewed … Busch et al. BMC Cancer. 2012; 13: 211.

  3. Common mistakes Effective writing  Compared with is for comparing similar things  Compared to is for comparing different things The tumors of the treatment group were compared to those of the control group. The tumors of the treatment group were compared with those of the control group.

  4. Common mistakes Effective writing Data is the plural form of datum The data was analyzed ... This data suggests … The data were analyzed … These data suggest …

  5. Common mistakes Effective writing Avoid qualitative terms: – Few, most, generally, very, etc. We observed a slight decrease in LDL levels after treatment. LDL levels only decreased from 3.87 to 3.62 mmol/L after treatment.

  6. Common mistakes Effective writing “I should use complex words to make my writing more impressive.” Nature ’s guide to authors: Nature is an international journal covering all the sciences. Contributions should therefore be written clearly and simply so that they are accessible to readers in other disciplines and to readers for whom English is not their first language. www.nature.com/nature/authors/gta/index.html#a4

  7. Effective writing Avoid complex words To ascertain the efficaciousness of the program, we interrogated the participants upon completion. To determine the success of the program, we questioned the participants upon completion.

  8. Effective writing Avoid complex words Avoid Preferred Adequate Enough Advantageous Helpful Apparent Clear Ascertain Determine Commence Begin Endeavor Try Requested Asked Retain Keep Terminate End Utilization Use

  9. Any questions? Break edanzediting.com/ftm_2015 Download and further reading @EdanzEditing, @JeffreyRobens Follow us on Twitter facebook.com/EdanzEditing Like us on Facebook

  10. Section 4 Manuscript structure

  11. Coverage and Manuscript Introduction Staffing Plan structure General introduction Current state of the field Problem in the field Aims Specific aims

  12. Coverage and Manuscript Writing the Introduction Staffing Plan structure The aims should directly address the problem Problem Currently, the standard procedure used to evaluate hepatic steatosis is the histopathological examination of cross-liver sections … … this is an invasive practice that presents inherent risks ... Therefore, it is essential to establish new non-invasive approaches to accurately determine hepatic fat concentration … Aims The purpose of our prospective study … was to evaluate the potential of multi-echo MRI to quantitate the hepatic triglyceride concentration. Jiménez-Agüero et al. BMC Med. 2014; 12:137.

  13. Coverage and Manuscript Methods Staffing Plan structure Study design • Demographics Participants • Enrollment procedure used • Inclusion/exclusion criteria • Treatments (controls) How the study • Patient management was done • Follow-up • Quantification methods • Statistical tests Data analysis – Consult a statistician

  14. Coverage and Manuscript Resources for statistics Staffing Plan structure http://www.nature.com/collections/qghhqm http://www.bmj.com/specialties/statistics-notes

  15. Coverage and Manuscript Results Staffing Plan structure 1. Study design 2. Treatment efficacy Logical presentation 3. Safety Each subsection Subsections corresponds to one figure What you found, not Factual description what it means

  16. Coverage and Manuscript Discussion Staffing Plan structure Summary of findings Relevance of findings Similarities/differences Unexpected/negative results Limitations Clinical Conclusion implications

  17. Writing a strong Coverage and Manuscript Staffing Plan conclusion paragraph structure Why your study is important In conclusion, we found an independent, graded association Conclusion between lower levels of the estimated GFR and the risks of death, cardiovascular events, and hospitalization. These risks Key finding were evident at an estimated GFR of less than 60 ml per minute per 1.73 m 2 and substantially increased with an estimated GFR of less than 45 ml per minute per 1.73 m 2 . Our Implications findings support the validity of the National Kidney Foundation staging system for chronic kidney disease but suggest that the Future system could be further refined, since all persons with stage 3 directions chronic kidney disease (GFR, 30 to 59 ml per minute per 1.73 m 2 ) may not be at equal risk for each outcome. Our findings Clinical highlight the clinical and public health importance of chronic importance kidney disease that does not necessitate dialysis. Go et al. N Engl J Med. 2004; 351: 1296 – 1305.

  18. Linking your ideas in Coverage and Manuscript Staffing Plan your manuscript structure Background Current state of the field Introduction Problems in the field Objectives Methods Methodology Results Results and figures Summary of findings Discussion Relevance of findings Clinical implications Logically link your ideas throughout your manuscript

  19. Coverage and Manuscript Effective titles Staffing Plan structure Important points Avoid  Summarize key finding Questions  Contains keywords Describing methods  States study design Abbreviations  Less than 20 words “New” or “novel” Your title should be a concise summary of your most important finding

  20. Coverage and Manuscript Abstracts Staffing Plan structure Relevance of Importance of Validity of your your aims your results conclusions First impression of your paper Judge your Probably only part writing style that will be read

  21. Coverage and Manuscript Sections of an abstract Staffing Plan structure Concise summary of your research Why does this trial/case Background need to be reported? Patients and Patient information methods Interventions given Treatment outcomes Results Adverse events Clinical relevance Conclusion Learning points Source of funding and trial registration number

  22. Coverage and Manuscript Unstructured abstract Staffing Plan structure Numerous systemic treatment options exist for patients with mycosis fungoides (MF) and Sézary syndrome (SS); however, the comparative efficacy of these treatments is unclear. We performed a retrospective analysis of our cutaneous lymphoma database to evaluate the treatment efficacy of 198 MF/SS patients undergoing systemic therapies. The primary end point was time to next treatment (TTNT). Patients with advanced-stage disease made up 53%. The median follow-up time from diagnosis for all alive patients was 4.9 years (range 0.3 ‒ 39.6), with a median survival of 11.4 years. Patients received a median of 3 lines of therapy (range 1 ‒ 13), resulting in 709 treatment episodes. Twenty- eight treatment modalities were analyzed. We found that the median TTNT for single- or multiagent chemotherapy was only 3.9 months (95% confidence interval [CI] 3.2 ‒ 5.1), with few durable remissions. α -interferon gave a median TTNT of 8.7 months (95% CI 6.0-18.0), and histone deacetylase inhibitors (HDACi) gave a median TTNT of 4.5 months (95% CI 4.0 ‒ 6.1). When compared directly with chemotherapy, interferon and HDACi both had greater TTNT ( P < .00001 and P = .01, respectively). In conclusion, this study confirms that all chemotherapy regimens assessed have very modest efficacy; we recommend their use be restricted until other options are exhausted. Modified from : Cannegieter et al. Blood. 2015; 125: 229‒235.

  23. Coverage and Manuscript Unstructured abstract Staffing Plan structure Numerous systemic treatment options exist for patients with mycosis fungoides (MF) and Background Sézary syndrome (SS); however, the comparative efficacy of these treatments is unclear. We performed a retrospective analysis of our cutaneous lymphoma database to evaluate the treatment efficacy of 198 MF/SS patients undergoing systemic therapies. The primary end point was time to next treatment (TTNT). Patients with advanced-stage disease Methods made up 53%. The median follow-up time from diagnosis for all alive patients was 4.9 years (range 0.3 ‒ 39.6), with a median survival of 11.4 years. Patients received a median of 3 lines of therapy (range 1 ‒ 13), resulting in 709 treatment episodes. Twenty-eight treatment modalities were analyzed. We found that the median TTNT for single- or multiagent chemotherapy was only 3.9 months (95% confidence interval [CI] 3.2 ‒ 5.1), with few durable remissions. α -interferon gave a median TTNT of 8.7 months (95% CI 6.0-18.0), and histone deacetylase inhibitors Results (HDACi) gave a median TTNT of 4.5 months (95% CI 4.0 ‒ 6.1). When compared directly with chemotherapy, interferon and HDACi both had greater TTNT ( P < .00001 and P = .01, respectively). In conclusion, this study confirms that all chemotherapy regimens assessed have very Conclusion modest efficacy; we recommend their use be restricted until other options are exhausted. Implications Modified from : Cannegieter et al. Blood. 2015; 125: 229‒235.

  24. Coverage and Manuscript Writing your abstract Staffing Plan structure Numerous systemic treatment options exist for patients with mycosis fungoides (MF) Why needed to be done and Sézary syndrome (SS); however, the comparative efficacy of these treatments is unclear. We performed a retrospective analysis of our cutaneous lymphoma database to evaluate the treatment efficacy of 198 MF/SS patients undergoing systemic therapies. The primary end point was time to next treatment (TTNT). Patients with advanced-stage What you did disease made up 53%. The median follow-up time from diagnosis for all alive patients was 4.9 years (range 0.3 ‒ 39.6), with a median survival of 11.4 years. Patients received a median of 3 lines of therapy (range 1 ‒ 13), resulting in 709 treatment episodes. Twenty- eight treatment modalities were analyzed. We found that the median TTNT for single- or multiagent chemotherapy was only 3.9 months (95% confidence interval [CI] 3.2 ‒ 5.1), with few durable remissions. α -interferon gave a median TTNT of 8.7 months (95% CI What you found 6.0-18.0), and histone deacetylase inhibitors (HDACi) gave a median TTNT of 4.5 months (95% CI 4.0 ‒ 6.1). When compared directly with chemotherapy, interferon and HDACi both had greater TTNT ( P < .00001 and P = .01, respectively). In conclusion, this study confirms that all chemotherapy regimens assessed have very modest efficacy; we How contributes to the field recommend their use be restricted until other options are exhausted. Modified from : Cannegieter et al. Blood. 2015; 125: 229‒235.

  25. Section 5 Communicating with journals

  26. When to choose a Communicating with journals journal? Choose the journal before you write your manuscript Author guidelines Aims and scope • Manuscript structure • Topics • Word limits • Readership • Reference style • Be sure to emphasize *Recently published article Relevant references Writing style

  27. Communicating Evaluating significance with journals How new are your findings? Novelty Low or high impact journal How broadly relevant are your findings? Relevance International/regional & general/specialized

  28. Factors to consider when Communicating with journals choosing a journal Aims & scope Readership Indexing Open access Impact factor • Health policy • Private clinicians Which factor is most important to you?

  29. Journal Selector Communicating with journals www.edanzediting.com/journal_selector Insert your proposed abstract or keywords

  30. Journal Selector Communicating with journals www.edanzediting.com/journal_selector Journal’s aims & scope, IF, and publication frequency Filter by: • Field of study • Impact factor • Indexed in SCI • Open access • Publishing frequency

  31. Journal Selector Communicating with journals www.edanzediting.com/journal_selector • Author guidelines • Journal website Similar published articles  Are they currently publishing similar articles?  Have you cited any of these articles?

  32. Communicating Cover letters with journals Significance Why your work Relevance is important! First impression for journal editors Interesting to Writing style their readers?

  33. Communicating A good cover letter with journals Manuscript title Editor’s name Dear Dr Lippman, Please find enclosed our manuscript entitled “Evaluation of the Glasgow prognostic score in patients undergoing curative resection for breast cancer liver metastases,” which we would like to submit for publication as an Original Article in the Breast Article type Cancer Research and Treatment . The Glasgow prognostic score (GPS) is of value for a variety of tumours. Several studies have investigated the prognostic value of Give the the GPS in patients with metastatic breast cancer, but few studies have performed such an investigation for patients undergoing background to liver resection for liver metastases. Furthermore, there are currently no studies that have examined the prognostic value of the modified GPS (mGPS) in these patients. The present study evaluated the mGPS in terms of its prognostic value for postoperative the research death in patients undergoing liver resection for breast cancer liver metastases. A total of 318 patients with breast cancer liver metastases who underwent hepatectomy over a 15-year period were included in What was this study. The mGPS was calculated based on the levels of C-reactive protein and albumin, and the disease-free survival and cancer-specific survival rates were evaluated in relation to the mGPS. Prognostic significance was retrospectively analyzed by done and what univariate and multivariate analyses. Overall, the results showed a significant association between cancer-specific survival and was found the mGPS and carcinoembryonic antigen level, and a higher mGPS was associated with increased aggressiveness of liver recurrence and poorer survival in these patients. This study is the first to demonstrate that the preoperative mGPS, a simple clinical tool, is a useful prognostic factor for postoperative survival in patients undergoing curative resection for breast cancer liver metastases. This information is Interest to immediately clinically applicable for oncologists treating such patients. As a premier journal covering the broad field of cancer, journal’s readers we believe that the Breast Cancer Research and Treatment is the perfect platform from which to share our results with the international medical community.

  34. Peer review – What Communicating reviewers are looking for with journals  Relevant hypothesis  Good experimental design The study  Appropriate methodology  Good data analysis  Valid conclusions  Logical flow of information  Manuscript structure and formatting The manuscript  Appropriate references  High readability

  35. Communicating Response letters with journals Revise your manuscript according to reviewer comments Communicate revisions to the journal editor

  36. Communicating Writing response letters with journals Read by the journal editor, not the reviewers Respond to every reviewer comment Refer to line and page numbers Use a different color font Easy to see changes Highlight the text Highlight the text Strikethrough font for deletions

  37. Communicating Agreeing with reviewers with journals Reviewer Comment: In your analysis of the data you have chosen to use a somewhat obscure fitting function (regression). In my opinion, a simple Gaussian function would have sufficed. Moreover, the results would be more instructive and easier to compare to previous results. Agreement Response: We agree with the Reviewer’s assessment of the analysis. Journal editors want to know why you agree and what changes you made

  38. Communicating Agreeing with reviewers with journals Reviewer Comment: In your analysis of the data you have chosen to use a somewhat obscure fitting function (regression). In my opinion, a simple Gaussian function would have sufficed. Moreover, the results would be more instructive and easier to compare to previous results. Agreement Response: We agree with the Reviewer’s assessment of the analysis. Our tailored function, in its current form, makes it difficult to tell that this measurement constitutes a significant Why agree improvement over previously reported values. We describe our new analysis using a Gaussian fitting function in our revised Results section (Page 6, Lines 12 – 18). Revisions Location

  39. Communicating Disagreeing with reviewers with journals Reviewer Comment: In your analysis of the data you have chosen to use a somewhat obscure fitting function (regression). In my opinion, a simple Gaussian function would have sufficed. Moreover, the results would be more instructive and easier to compare to previous results. Response: It is clear that this reviewer is not familiar with the current analytical methods in the field. I recommend that you identify a more suitable reviewer for my manuscript.

  40. Communicating Disagreeing with reviewers with journals Reviewer Comment: In your analysis of the data you have chosen to use a somewhat obscure fitting function (regression). In my Support your claim opinion, a simple Gaussian function would have sufficed. with evidence Moreover, the results would be more instructive and easier to compare to previous results. Response: Although a simple Gaussian fit would facilitate Evidence comparison with the results of other studies, our tailored function allows for the analysis of the data in terms of the Smith model [Smith et al., 1998]. We have now explained the use of this function and the Smith model in our revised Discussion section Revisions (Page 12, Lines 2 – 6). Location

  41. Section 6 Succeeding with Edanz

  42. Succeeding Overview with Edanz • Introduction – who we are, what we do • Using Edanz services • Deciding which services you need S • Process • Payments • Contacting us • Working well together

  43. Succeeding What we do with Edanz Language editing for the academic publishing industry  Support individual authors  Work with universities and institutes S  Collaborate with publishers We prepare manuscripts to pass through submission and peer review

  44. Succeeding Who we are with Edanz Edanz vision Raise authors’ S chances of acceptance for publication

  45. Succeeding Our experts with Edanz How are we different?  Native English speakers  Research experience S  Publishing experience  In-depth knowledge of the manuscript’s content  High language and editorial skills

  46. Succeeding Our experts with Edanz Daniel wheeler 2009 - DM Critical Care and Anaesthesiology, University of Oxford 2006 - PhD Neurobiology, University of Cambridge 1994 - BM BCh Clinical Medicine, University of Oxford • Lecturer and honorary consultant anaesthetist at the University of Cambridge • Member of the Royal College of Physicians since 1997 • Published over 40 scientific papers S Ludovic Croxford 2000 - PhD Medical Immunology, University College London 1994 - BSc Biochemistry and Toxicology, University of Surrey • Multi-disciplinary immunologist with research experience in a wide range of fields, especially neuroimmunology, autoimmunity and oncology • Published over 40 peer-reviewed papers , reviews and book chapters in journals including Nature , Nature Immunology and Nature Medicine

  47. Our publisher Succeeding with Edanz partnerships S

  48. Why are we working with the Succeeding with Edanz Faculty of Tropical Medicine?  To raise the number and quality of journal publications  To support FTM authors during the S publication process  To make access to high quality services easy and cost-effective

  49. Succeeding Key people at Edanz with Edanz Dr William Yajima Senior Editor and Project Manager S Ms Megumi Hara Global Customer Service

  50. Succeeding Using our services with Edanz 1. Assess which services you need 2. Use the FTM portal S 3. Send us all the appropriate files

  51. Succeeding Our services with Edanz 1. Language editing • Language edit - compulsory • Second edit • Review edit • Point by point edit 2. Content services S • Journal selection • Expert scientific review • Cover letter development • Reviewer recommendation • Abstract development • Custom services (e.g., rewriting, reformatting)

  52. Succeeding Our services with Edanz 1. Language editing • Language edit - compulsory • Second edit • Language editing: Review edit • Point by point edit  Edits for grammar, clarity and accuracy of scientific expression 2. Content services S  Clearly communicates the novelty and significance of your • Journal selection research • Expert scientific review •  Edits to the requirements of your target journal Cover letter development • Reviewer recommendation • Abstract development • Custom services (e.g., rewriting, reformatting)

  53. Succeeding Our services with Edanz 1. Language editing • Language edit - compulsory • Second edit • Review edit Second edit: • Point by point edit  Strongly recommended! 2. Content services S  Send it back for more help or clarification • Journal selection • Expert scientific review  Revise your manuscript, add data, respond to questions • Cover letter development • Reviewer recommendation • Abstract development • Custom services (e.g., rewriting, reformatting)

  54. Succeeding Our services with Edanz 1. Language editing • Language edit - compulsory • Second edit • Review edit • Point by point edit Review edit: 2. Content services  After peer review S • Journal selection  After you have revised your manuscript • Expert scientific review • Cover letter development • Reviewer recommendation • Abstract development • Custom services (e.g., rewriting, reformatting)

  55. Succeeding Our services with Edanz 1. Language editing • Language edit - compulsory Point-by-point edit: • Second edit • Review edit  After peer review • Point by point edit  After you have revised your manuscript 2. Content services S  After you have written your response letter • Journal selection • Expert scientific review  Edanz will check: • Cover letter development • Responses Appropriate & correct • Reviewer recommendation • Revisions • Abstract development • Custom services (e.g., rewriting, reformatting)

  56. Succeeding Our services with Edanz 1. Language editing • Language edit - compulsory • Second edit Expert scientific review: • Review edit • Point by point edit  Pre-submission peer review 2. Content services  Support revising a rejected manuscript S • Journal selection  Expect to make revisions after the review • Expert scientific review • Cover letter development  Expect to supply new data or rationale • Reviewer recommendation • Abstract development • Custom services (e.g., rewriting, reformatting)

  57. Succeeding Our services with Edanz 1. Language editing • Language edit - compulsory • Second edit Journal selection: • Review edit • Point by point edit  Help choosing the most appropriate target journal 2. Content services • Tell us your preferences (we might not agree!) S • Journal selection • Tell us the submission history • Expert scientific review • Cover letter development • Be objective and strategic • Reviewer recommendation • Abstract development • Custom services (e.g., rewriting, reformatting)

  58. Succeeding Our services with Edanz 1. Language editing • Language edit - compulsory • Second edit • Review edit Cover letter or abstract development, Reviewer • Point by point edit recommendations: 2. Content services S  We write an Abstract or cover letter • Journal selection • Expert scientific review  We find 4 appropriate reviewers • Cover letter development • Reviewer recommendation • Abstract development • Custom services (e.g., rewriting, reformatting)

  59. Succeeding Our services with Edanz 1. Language editing • Language edit - compulsory • Second edit • Review edit Custom services: • Point by point edit  Rewriting, revising, responding, combining, shortening, etc. 2. Content services S  Reformatting for new journal • Journal selection • Expert scientific review  Need something else? Please let us know! • Cover letter development • Reviewer recommendation • Abstract development • Custom services (e.g., rewriting, reformatting)

  60. Faculty of Tropical Succeeding with Edanz Medicine portal S

  61. Faculty of Tropical Succeeding with Edanz Medicine portal S

  62. Succeeding Remember to… with Edanz  Always use the FTM portal  Upload all relevant files  Tell us the submission history ; send us reviewer comments S  Maximum value • Use the second edit • Respond to questions and comments • Revise/reformat when necessary

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend